What Causes Restless Legs with Fibroids?

What Causes Restless Legs with Fibroids?

Restless legs with fibroids are most commonly caused by iron deficiency from chronic heavy bleeding, compounded by elevated estrogen levels that further suppress dopamine signaling in the central nervous system. The effect is real and measurable — low ferritin is one of the strongest modifiable risk factors for RLS — but severity varies widely depending on how much blood you lose each cycle and your baseline iron stores.

---

Why Fibroids and Restless Legs Are Biologically Linked

Uterine fibroids are estrogen-sensitive tumors. They grow in estrogen-rich environments, and they cause heavy menstrual bleeding — sometimes dramatically so. That combination creates a two-pronged attack on the neurological systems that regulate leg comfort during sleep.

Pathway 1: Iron Depletion Through Blood Loss

Fibroids are the leading gynecological cause of heavy menstrual bleeding (HMB), defined as losing more than 80 mL of blood per cycle. A large 2021 systematic review found that iron deficiency anemia affects 59–75% of women with symptomatic fibroids (Donnez & Dolmans, Human Reproduction Update 2021; PMID: 33515043). Iron is not just a red blood cell component — it is a required cofactor for tyrosine hydroxylase, the enzyme that synthesizes dopamine. When ferritin falls below roughly 50–75 ng/mL, dopamine production in the substantia nigra becomes rate-limited, and spinal cord dopamine receptor sensitivity drops. The result is the characteristic urge-to-move that defines RLS.

A landmark study by Allen et al. confirmed that low serum ferritin — even in the absence of frank anemia — is independently associated with RLS severity, and that intravenous iron supplementation reduced RLS symptom scores significantly in iron-deficient patients (Allen et al., Sleep Medicine 2013; PMID: 23026535).

Pathway 2: Estrogen's Effect on Dopamine Receptors

Fibroids do not just cause bleeding; they actively produce and respond to estrogen. Elevated circulating estrogen has been shown to downregulate D2 dopamine receptor expression in the mesolimbic and nigrostriatal pathways (Chavez et al., Neuropsychopharmacology 2010; PMID: 20736997). This matters because RLS is fundamentally a dopamine dysregulation disorder. Treatments that restore dopamine activity — including dopamine agonists like pramipexole — are first-line pharmaceutical therapy for RLS. When estrogen suppresses receptor sensitivity, the threshold for RLS symptoms falls, meaning you need less iron deficiency to trigger symptoms than you would under normal hormonal conditions.

This is why women with fibroids who also have symptoms like anxiety with fibroids or crying easily often notice these issues worsen in the luteal phase — that is when estrogen is highest relative to progesterone, compounding the dopamine suppression.

---

The Iron-Ferritin-Dopamine Axis: A Closer Look

Many clinicians still rely on hemoglobin alone to screen for iron status, but for RLS this is the wrong test. Hemoglobin can remain normal while ferritin — the storage form of iron — is critically depleted. The brain requires iron independently of hemoglobin; cerebrospinal fluid ferritin in RLS patients is measurably lower than in controls even when serum ferritin is borderline normal.

Here is how the chain of events typically unfolds in a woman with fibroids:

1. Heavy monthly bleeding reduces total body iron stores.
2. Ferritin drops below the threshold needed for optimal tyrosine hydroxylase activity.
3. Dopamine synthesis and receptor sensitivity in spinal pain-modulating circuits falls.
4. The sensorimotor restlessness loop activates — particularly between 8 PM and 4 AM when circadian dopamine release is naturally lowest.
5. Sleep fragmentation follows, which further dysregulates cortisol and exacerbates hormonal imbalance.

This cycle is self-reinforcing. Poor sleep elevates cortisol, which promotes estrogen dominance by suppressing progesterone, which in turn feeds fibroid growth and heavier bleeding (Laughlin & Barrett-Connor, Journal of Clinical Endocrinology & Metabolism 2000; PMID: 10720055).

---

Key Biomarkers to Check

If you have fibroids and experience restless legs, the following lab panel will give you actionable data:

Ferritin is the most critical number. If it is under 50 ng/mL and you have fibroids, iron repletion should be the first intervention explored with your healthcare provider before anything else.

---

Magnesium, Vitamin D, and the Supporting Cast

Iron is the primary driver, but it is rarely the only deficiency at play. Women with fibroids commonly show low magnesium and suboptimal vitamin D — both of which influence neurological and muscular function in ways relevant to RLS.

Magnesium acts as a natural NMDA receptor antagonist. It modulates the excitatory glutamate signaling that, when unchecked, contributes to the sensory hypersensitivity of RLS. A controlled trial found that magnesium supplementation improved RLS symptoms and overall sleep quality in patients with periodic limb movement disorder (Hornyak et al., Sleep 1998; PMID: 9703590). While this study is older, it remains clinically referenced because the NMDA mechanism it demonstrated is well-replicated.

Vitamin D3 is a neuroactive steroid that upregulates tyrosine hydroxylase gene expression — the same dopamine-synthesis enzyme impaired by iron deficiency. Observational data consistently show lower 25-OH vitamin D levels in RLS patients compared to controls, although randomized trial data is still emerging.

These deficiencies do not operate in isolation from fibroid pathology. Fibroids are associated with systemic inflammation and oxidative stress, both of which increase micronutrient consumption. The same inflammatory milieu that drives weight gain around the middle with fibroids also depletes antioxidant minerals including magnesium and zinc.

---

Hormonal Mechanisms: Estrogen Dominance and Progesterone Deficiency

Estrogen dominance — whether from fibroid-driven estrogen production, impaired liver clearance, or relative progesterone insufficiency — is the hormonal backdrop against which RLS worsens.

Progesterone has a direct calming effect on the central nervous system. It acts as a positive allosteric modulator of GABA-A receptors through its metabolite allopregnanolone. When progesterone is low, GABA-mediated inhibition decreases, the nervous system becomes more excitable, and the threshold for sensorimotor symptoms like RLS drops further.

This is consistent with clinical observation: RLS symptoms in women with fibroids tend to be worst in the week before menstruation, when progesterone has already declined but estrogen remains relatively elevated. Symptoms often improve — though do not disappear — after menstruation begins and blood loss reduces circulating estrogen.

Women who also experience restless legs with PMS will recognize this pattern acutely. The mechanism is essentially the same hormonal disruption on a different underlying anatomical canvas.

---

Inflammation, Prostaglandins, and Nervous System Sensitization

Fibroids generate local and systemic inflammation. They produce elevated prostaglandin E2 and thromboxane, which not only cause painful cramps but also sensitize peripheral nociceptors. This is part of why fibroid-related pain often extends beyond the pelvis — joint pain with fibroids and muscle loss with fibroids share this inflammatory pathway.

In the context of RLS, central sensitization is relevant. When the spinal cord's pain-modulating circuits are already primed by chronic inflammation, the threshold for perceiving discomfort in the extremities falls. RLS may therefore be partly a manifestation of heightened central nervous system sensitivity rather than purely a peripheral muscle disorder — which explains why addressing inflammation as well as iron is often necessary for full symptom resolution.

---

Practical Protocol: A Tiered Approach

Before starting any supplement protocol, consult your healthcare provider — especially regarding iron dosing, which can cause harm at excessive levels.

Tier 1: Address Iron Deficiency (the most impactful intervention)

1. Get serum ferritin, hemoglobin, serum iron, and TIBC tested.
2. If ferritin is under 50 ng/mL, discuss iron supplementation with your doctor. Ferrous bisglycinate is gentler on the GI tract than ferrous sulfate and has comparable absorption (Szarfarc et al., Archivos Latinoamericanos de Nutrición 2001).
3. Take iron on an empty stomach with 250 mg vitamin C to enhance absorption; avoid coffee, tea, and calcium supplements within 2 hours.
4. Recheck ferritin at 8–12 weeks. Target ≥ 75 ng/mL for neurological benefit.

Tier 2: Correct Supporting Deficiencies

1. Test RBC magnesium and 25-OH vitamin D.
2. If magnesium is suboptimal, consider magnesium glycinate (the glycinate form crosses the blood-brain barrier efficiently) at 200–400 mg elemental magnesium per day, taken in the evening.
3. If vitamin D is below 40 ng/mL, discuss D3 supplementation (typically 2,000–5,000 IU/day) with K2 (MK-7 form, 90–180 mcg) to support proper calcium metabolism.

Tier 3: Support Hormonal Balance

1. Optimize liver function — impaired hepatic estrogen clearance worsens estrogen dominance. DIM (diindolylmethane) and calcium-D-glucarate support Phase I and Phase II liver metabolism of estrogen.
2. Reduce phytoestrogen load from processed soy; increase cruciferous vegetable intake.
3. Consider adaptogenic support for the HPA axis if cortisol dysregulation is contributing to the progesterone deficit.

Tier 4: Sleep and Circadian Hygiene

1. Maintain consistent sleep and wake times — dopamine release follows a circadian rhythm, and irregular schedules worsen the nocturnal trough.
2. Avoid prolonged sitting in the evening; light walking or calf raises before bed can temporarily relieve RLS urgency.
3. Minimize caffeine after 2 PM; caffeine competes with adenosine receptors and may exacerbate RLS sensory sensitivity.

---

What This Means for Your Formula

Ones uses an AI health practitioner to analyze your blood work, wearable data, and health history before building a personalized capsule formula. For someone with fibroids and RLS symptoms, the nutritional gaps most likely to show up in that analysis — and most directly addressed by Ones' ingredient catalog — include:

• Magnesium Glycinate: Ones includes this in clinical doses (up to 400 mg elemental) within its Magnesium Complex blend, specifically for neuromuscular and sleep applications. This aligns with the NMDA-modulating mechanism relevant to RLS.
• Vitamin D3 + K2 (MK-7): Ones pairs D3 with MK-7 in a single capsule to support both the neuroactive and musculoskeletal functions of vitamin D, with doses calibrated to your actual 25-OH D level from lab results rather than a one-size-fits-all amount.
• Adrenal Support (System Blend): Where cortisol dysregulation is identified as a driver of hormonal imbalance, Ones' Adrenal Support blend addresses the HPA axis — the upstream regulator of the progesterone deficit that compounds RLS in fibroid patients.

Ones does not stock an iron supplement (because iron dosing requires confirmed lab-based deficiency and medical oversight), but its formulas are designed to complement the broader micronutrient protocol you build with your healthcare provider.

---

Key Takeaways

• Iron deficiency is the primary driver: Fibroids cause heavy bleeding, which depletes ferritin below the threshold needed for adequate dopamine synthesis — the core mechanism of restless legs syndrome.
• Estrogen excess compounds the problem: Elevated estrogen from fibroid activity suppresses D2 dopamine receptor expression, lowering the symptom threshold even further.
• Ferritin, not hemoglobin, is the key test: You can have normal hemoglobin and still have brain-level iron deficiency sufficient to trigger RLS. Target ferritin ≥ 75 ng/mL.
• Magnesium and vitamin D3 are meaningful supporting players: Both influence dopamine synthesis and neurological excitability; deficiencies are common in fibroid patients and measurably worsen RLS.
• The inflammation-sensitization loop matters: Fibroid-driven prostaglandin production sensitizes the central nervous system, lowering the threshold for all sensorimotor symptoms including RLS.
• A tiered, lab-guided protocol is more effective than guesswork: Address iron first, correct supporting deficiencies second, support hormonal clearance third — and always confirm deficiencies with bloodwork before supplementing.

---

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before beginning any supplement or treatment protocol, particularly for iron supplementation.